Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression

Figure 4 Systemic and local cytokine profile of patients with especially same clinical, endoscopic and histopathological stage of ulcerative colitis, according to metabolic syndrome. Patients with ulcerative colitis (UC) were divided into groups according to clinical, endoscopic and histopathological stage of UC, respectively. A: Interleukin-17 were measured by ELISA in the sera of UC patients without and with metabolic syndrome (MetS). B: Interleukin-10 were measured by ELISA in the sera of UC patients without and with MetS. C: Galectin-3 were measured by ELISA in the sera of UC patients without and with MetS. The Student’s t or Mann-Whitney U test was applied as appropriate to evaluate statistical significant differences. IL-17: Interleukin-17; IL-10: Interleukin-10; Gal-3: Galectin-3.